Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials

A Maurer-Cecchini; S Decuypere; F Chappuis; C Alexandrenne; S De Doncker; M Boelaert; JC Dujardin; L Loutan; JM Dayer; G Tulliano; J Arevalo; A Llanos-Cuentas; C Chizzolini

doi:10.1128/IAI.01513-08

Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials

A Maurer-Cecchini, S Decuypere, F Chappuis, C Alexandrenne, S De Doncker, M Boelaert, JC Dujardin, L Loutan, JM Dayer, G Tulliano, J Arevalo, A Llanos-Cuentas, C Chizzolini

Research output: Contribution to journal › A1: Web of Science-article › peer-review

Original language	English
Journal	Infection and Immunity
Volume	77
Issue number	5
Pages (from-to)	2022-2029
Number of pages	8
ISSN	0019-9567
DOIs	https://doi.org/10.1128/IAI.01513-08
Publication status	Published - 2009

Keywords

B780-tropical-medicine
Protozoal diseases
Leishmaniasis
Tegumentary
Drug therapy
Antimonials
Treatment outcomes
Immune response
mRNA
Interferon-gamma
Tumor necrosis factor alpha
Interleukin-10
Interleukin-4
Interleukin-13
T-cells
Macrophages
Peru
America-Latin

Access to Document

10.1128/IAI.01513-08

http://lib.itg.be/pdf/itg/2009/2009iimm2022.pdf

Cite this

Maurer-Cecchini, A., Decuypere, S., Chappuis, F., Alexandrenne, C., De Doncker, S., Boelaert, M., Dujardin, JC., Loutan, L., Dayer, JM., Tulliano, G., Arevalo, J., Llanos-Cuentas, A., & Chizzolini, C. (2009). Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials. Infection and Immunity, 77(5), 2022-2029. https://doi.org/10.1128/IAI.01513-08

@article{2b2ba38da5bb47b9a6373632f5720fc0,

title = "Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials",

keywords = "B780-tropical-medicine, Protozoal diseases, Leishmaniasis, Tegumentary, Drug therapy, Antimonials, Treatment outcomes, Immune response, mRNA, Interferon-gamma, Tumor necrosis factor alpha, Interleukin-10, Interleukin-4, Interleukin-13, T-cells, Macrophages, Peru, America-Latin",

author = "A Maurer-Cecchini and S Decuypere and F Chappuis and C Alexandrenne and {De Doncker}, S and M Boelaert and JC Dujardin and L Loutan and JM Dayer and G Tulliano and J Arevalo and A Llanos-Cuentas and C Chizzolini",

note = "ITG-P2B; ITG-P5B; ITG-H6A; ITG-P7A; MULTI; PARAS; U-PROTO; HEALTH; U-EPID; JIF; DOI; PDF; DSPACE",

year = "2009",

doi = "10.1128/IAI.01513-08",

language = "English",

volume = "77",

pages = "2022--2029",

journal = "Infection and Immunity",

issn = "0019-9567",

publisher = "American Society for Microbiology",

number = "5",

}

Maurer-Cecchini, A, Decuypere, S, Chappuis, F, Alexandrenne, C, De Doncker, S, Boelaert, M, Dujardin, JC, Loutan, L, Dayer, JM, Tulliano, G, Arevalo, J, Llanos-Cuentas, A & Chizzolini, C 2009, 'Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials', Infection and Immunity, vol. 77, no. 5, pp. 2022-2029. https://doi.org/10.1128/IAI.01513-08

TY - JOUR

T1 - Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials

AU - Maurer-Cecchini, A

AU - Decuypere, S

AU - Chappuis, F

AU - Alexandrenne, C

AU - De Doncker, S

AU - Boelaert, M

AU - Dujardin, JC

AU - Loutan, L

AU - Dayer, JM

AU - Tulliano, G

AU - Arevalo, J

AU - Llanos-Cuentas, A

AU - Chizzolini, C

N1 - ITG-P2B; ITG-P5B; ITG-H6A; ITG-P7A; MULTI; PARAS; U-PROTO; HEALTH; U-EPID; JIF; DOI; PDF; DSPACE

PY - 2009

Y1 - 2009

KW - B780-tropical-medicine

KW - Protozoal diseases

KW - Leishmaniasis

KW - Tegumentary

KW - Drug therapy

KW - Antimonials

KW - Treatment outcomes

KW - Immune response

KW - mRNA

KW - Interferon-gamma

KW - Tumor necrosis factor alpha

KW - Interleukin-10

KW - Interleukin-4

KW - Interleukin-13

KW - T-cells

KW - Macrophages

KW - Peru

KW - America-Latin

U2 - 10.1128/IAI.01513-08

DO - 10.1128/IAI.01513-08

M3 - A1: Web of Science-article

SN - 0019-9567

VL - 77

SP - 2022

EP - 2029

JO - Infection and Immunity

JF - Infection and Immunity

IS - 5

ER -